Independent Research Analysts Give Draegerwerk AG & Co KGaA (ETR:DRW3) a €54.00 Price Target

Draegerwerk AG & Co KGaA (ETR:DRW3) has been assigned a €54.00 ($62.79) price target by stock analysts at Independent Research in a research report issued to clients and investors on Wednesday, Borsen Zeitung reports. The firm currently has a “neutral” rating on the stock. Independent Research’s target price would indicate a potential downside of 1.64% from the company’s previous close.

DRW3 has been the topic of a number of other reports. Deutsche Bank set a €46.00 ($53.49) target price on shares of Draegerwerk AG & Co KGaA and gave the stock a “neutral” rating in a research note on Wednesday, August 14th. Warburg Research set a €49.00 ($56.98) target price on shares of Draegerwerk AG & Co KGaA and gave the stock a “neutral” rating in a research note on Wednesday. Nord/LB set a €45.00 ($52.33) target price on shares of Draegerwerk AG & Co KGaA and gave the stock a “neutral” rating in a research note on Thursday, August 22nd. Finally, Hauck & Aufhaeuser set a €38.00 ($44.19) target price on shares of Draegerwerk AG & Co KGaA and gave the stock a “neutral” rating in a research note on Wednesday, August 14th. One equities research analyst has rated the stock with a sell rating and six have issued a hold rating to the company’s stock. The company presently has a consensus rating of “Hold” and a consensus target price of €45.57 ($52.99).

Shares of DRW3 opened at €54.90 ($63.84) on Wednesday. The stock has a market capitalization of $417.24 million and a PE ratio of 24.74. Draegerwerk AG & Co KGaA has a 1 year low of €38.32 ($44.56) and a 1 year high of €57.85 ($67.27). The company has a debt-to-equity ratio of 33.52, a quick ratio of 1.19 and a current ratio of 2.00. The company’s 50-day simple moving average is €44.78 and its 200-day simple moving average is €47.92.

Draegerwerk AG & Co KGaA Company Profile

Drägerwerk AG & Co KGaA develops equipment and solutions in the fields of medical and safety technology in Europe, Americas, Africa, Asia, and Australia. The company develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency care, perioperative care, critical care, and perinatal care.

Featured Story: How Investors Can Profit from Options Trading

Analyst Recommendations for Draegerwerk AG & Co KGaA (ETR:DRW3)

Receive News & Ratings for Draegerwerk AG & Co KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Draegerwerk AG & Co KGaA and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit